Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Soresi M"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1734
Tytuł:
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma.
Autorzy:
Giannitrapani L; Institute for Biomedical Research and Innovation, National Research Council (CNR), 90146 Palermo, Italy.; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
Di Gaudio F; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
Cervello M; Institute for Biomedical Research and Innovation, National Research Council (CNR), 90146 Palermo, Italy.
Scionti F; Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy.
Ciliberto D; Medical and Translational Oncology Unit, A.O.U. R. Dulbecco, 88100 Catanzaro, Italy.
Staropoli N; Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy.; Medical and Translational Oncology Unit, A.O.U. R. Dulbecco, 88100 Catanzaro, Italy.
Agapito G; Department of Legal, Economic and Social Sciences, Magna Graecia University, 88100 Catanzaro, Italy.
Cannataro M; Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Tassone P; Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy.; Medical and Translational Oncology Unit, A.O.U. R. Dulbecco, 88100 Catanzaro, Italy.; College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.
Tagliaferri P; Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy.; Medical and Translational Oncology Unit, A.O.U. R. Dulbecco, 88100 Catanzaro, Italy.
Seidita A; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.; Villa Sofia-Cervello Hospital, C.O.U. Medical Oncology, 90146 Palermo, Italy.
Soresi M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
Affronti M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
Bertino G; Hepatology Unit, A.O.U. Policlinico-San Marco, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Russello M; Liver Unit of ARNAS Garibaldi-Nesima, 95100 Catania, Italy.
Ciriminna R; Institute of Nanostructured Materials, National Research Council (CNR), 90146 Palermo, Italy.
Lino C; Institute of Nanostructured Materials, National Research Council (CNR), 90146 Palermo, Italy.
Spinnato F; Villa Sofia-Cervello Hospital, C.O.U. Medical Oncology, 90146 Palermo, Italy.
Verderame F; Villa Sofia-Cervello Hospital, C.O.U. Medical Oncology, 90146 Palermo, Italy.
Augello G; Institute for Biomedical Research and Innovation, National Research Council (CNR), 90146 Palermo, Italy.
Arbitrio M; Institute for Biomedical Research and Innovation, National Research Council (CNR), 88100 Catanzaro, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 12; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/metabolism
Antineoplastic Agents*/therapeutic use
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
Humans ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; Vascular Endothelial Growth Factor A/metabolism ; Niacinamide/therapeutic use ; Phenylurea Compounds/therapeutic use ; Genetic Markers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Can Baseline IL-6 Levels Predict Long COVID in Subjects Hospitalized for SARS-CoV-2 Disease?
Autorzy:
Giannitrapani L; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.; Institute for Biomedical Research and Innovation, National Research Council, 90146 Palermo, Italy.
Mirarchi L; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Amodeo S; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Licata A; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Soresi M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Cavaleri F; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Casalicchio S; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Ciulla G; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Ciuppa ME; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Cervello M; Institute for Biomedical Research and Innovation, National Research Council, 90146 Palermo, Italy.
Barbagallo M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
Veronese N; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.
The Comepa Group
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 15; Vol. 24 (2). Date of Electronic Publication: 2023 Jan 15.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Humans ; SARS-CoV-2 ; Post-Acute COVID-19 Syndrome ; Interleukin-6 ; Hospitalization
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
EVOO's Effects on Incretin Production: Is There a Rationale for a Combination in T2DM Therapy?
Autorzy:
Amodeo S; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Mirarchi L; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Seidita A; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Citarrella R; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Licata A; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Soresi M; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Iovanna JL; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, F-13288 Marseille, France.
Giannitrapani L; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.; Institute for Biomedical Research and Innovation (IRIB), National Research Council, Via U. La Malfa 153, 90146 Palermo, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 04; Vol. 23 (17). Date of Electronic Publication: 2022 Sep 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Dipeptidyl-Peptidase IV Inhibitors*/pharmacology
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Blood Glucose ; Glucagon-Like Peptide 1/physiology ; Humans ; Hypoglycemic Agents ; Incretins/therapeutic use ; Insulin Secretion
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease.
Autorzy:
Mirarchi L; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Amodeo S; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Citarrella R; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Licata A; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Soresi M; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Giannitrapani L; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.; Institute for Biomedical Research and Innovation (IRIB), National Research Council, 90146 Palermo, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Mar 27; Vol. 23 (7). Date of Electronic Publication: 2022 Mar 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/metabolism
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Liver Neoplasms*/drug therapy
Non-alcoholic Fatty Liver Disease*/complications
Sodium-Glucose Transporter 2 Inhibitors*/pharmacology
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Animals ; Glucose/therapeutic use ; Humans ; Hypoglycemic Agents/adverse effects ; Liver/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 1734

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies